NO20014969L - Diagnose av en persons risiko for utvikling av aterosklerose eller diabetisk retinopati - Google Patents

Diagnose av en persons risiko for utvikling av aterosklerose eller diabetisk retinopati

Info

Publication number
NO20014969L
NO20014969L NO20014969A NO20014969A NO20014969L NO 20014969 L NO20014969 L NO 20014969L NO 20014969 A NO20014969 A NO 20014969A NO 20014969 A NO20014969 A NO 20014969A NO 20014969 L NO20014969 L NO 20014969L
Authority
NO
Norway
Prior art keywords
person
development
diabetic retinopathy
risk
diagnosis
Prior art date
Application number
NO20014969A
Other languages
English (en)
Other versions
NO20014969D0 (no
Inventor
Markku Koulu
Matti Karvonen
Ullamari Pesonen
Matti Uusitupa
Original Assignee
Hormos Medical Oy Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hormos Medical Oy Ltd filed Critical Hormos Medical Oy Ltd
Publication of NO20014969L publication Critical patent/NO20014969L/no
Publication of NO20014969D0 publication Critical patent/NO20014969D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
NO20014969A 1999-04-15 2001-10-12 Diagnose av en persons risiko for utvikling av aterosklerose eller diabetisk retinopati NO20014969D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/291,994 US6312898B1 (en) 1999-04-15 1999-04-15 Diagnosis of a person's risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y gene
PCT/FI2000/000260 WO2000063430A1 (en) 1999-04-15 2000-03-29 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy

Publications (2)

Publication Number Publication Date
NO20014969L true NO20014969L (no) 2001-10-12
NO20014969D0 NO20014969D0 (no) 2001-10-12

Family

ID=23122742

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014969A NO20014969D0 (no) 1999-04-15 2001-10-12 Diagnose av en persons risiko for utvikling av aterosklerose eller diabetisk retinopati

Country Status (17)

Country Link
US (2) US6312898B1 (no)
EP (1) EP1169475B1 (no)
JP (1) JP2003521473A (no)
AT (1) ATE316153T1 (no)
AU (1) AU777917B2 (no)
CA (1) CA2363994A1 (no)
CZ (1) CZ20013549A3 (no)
DE (1) DE60025595T2 (no)
EE (1) EE200100533A (no)
ES (1) ES2251977T3 (no)
HU (1) HUP0200719A3 (no)
NO (1) NO20014969D0 (no)
NZ (1) NZ513189A (no)
PL (1) PL350620A1 (no)
RU (1) RU2238107C2 (no)
WO (1) WO2000063430A1 (no)
ZA (1) ZA200104775B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050107327A1 (en) * 1997-12-19 2005-05-19 Hormos Medical Corporation Method for reducing overproduction of neuropeptide Y in an individual
AU3381801A (en) * 2000-03-21 2001-10-03 Hormos Medical Corporation Diagnosis of a person's risk of developing alcoholism
US20040254131A1 (en) * 2003-06-16 2004-12-16 Markku Koulu Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels
US6979294B1 (en) * 2002-12-13 2005-12-27 California Institute Of Technology Split-screen display system and standardized methods for ultrasound image acquisition and processing for improved measurements of vascular structures
WO2005052593A1 (en) * 2003-10-29 2005-06-09 The University Of Leicester Detection
KR100961926B1 (ko) * 2007-08-30 2010-06-10 서울대학교산학협력단 당뇨병성 망막병증 검출용 바이오 마커 조성물 및 진단키트
ES2337115B2 (es) * 2007-09-26 2011-01-24 Universidade De Santiago De Compostela Metodo para la deteccion del riesgo de desarrollar vitreorretinopatiaproliferante (vrp).
US20100225239A1 (en) * 2009-03-04 2010-09-09 Purespectrum, Inc. Methods and apparatus for a high power factor, high efficiency, dimmable, rapid starting cold cathode lighting ballast
RU2465598C1 (ru) * 2011-09-07 2012-10-27 Государственное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого Министерства здравоохранения и социального развития Российской Федерации" Способ прогнозирования риска развития диабетической ретинопатии при сахарном диабете типа 2 у якутов
RU2461005C1 (ru) * 2011-09-07 2012-09-10 Государственное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого Министерства здравоохранения и социального развития Российской Федерации" Способ прогнозирования риска развития диабетической ретинопатии при сахарном диабете типа 2 у якуток
RU2533836C1 (ru) * 2013-09-25 2014-11-20 Государственное бюджетное образовательное учреждение высшего профессионального образования Воронежская государственная медицинская академия имени Н.Н. Бурденко Министерства здравоохранения Российской Федерации (ГБОУ ВПО ВГМА им. Н.Н. Бурденко Минздрава России) Способ мониторинга лиц с риском раннего развития атеросклероза и наличием сахарного диабета 2 типа

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455164A (en) 1989-11-03 1995-10-03 Mcgill University Ruminant immortalized mammary epithelial cell lines
US5714497A (en) * 1993-02-15 1998-02-03 Sanofi Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them
GB9406974D0 (en) 1994-04-08 1994-06-01 Pharmaceutical Proteins Ltd Transgenic production
GB9708918D0 (en) 1997-05-01 1997-06-25 Ppl Therapeutics Scotland Ltd Methods
SE9703414D0 (sv) * 1997-09-23 1997-09-23 Astra Ab New compounds

Also Published As

Publication number Publication date
CZ20013549A3 (cs) 2002-04-17
EP1169475A1 (en) 2002-01-09
RU2238107C2 (ru) 2004-10-20
DE60025595D1 (de) 2006-04-06
NZ513189A (en) 2003-05-30
WO2000063430A1 (en) 2000-10-26
US6312898B1 (en) 2001-11-06
EE200100533A (et) 2002-12-16
PL350620A1 (en) 2003-01-27
JP2003521473A (ja) 2003-07-15
EP1169475B1 (en) 2006-01-18
ES2251977T3 (es) 2006-05-16
HUP0200719A2 (en) 2002-06-29
ZA200104775B (en) 2002-06-12
US20050234008A1 (en) 2005-10-20
DE60025595T2 (de) 2006-11-16
CA2363994A1 (en) 2000-10-26
AU777917B2 (en) 2004-11-04
HUP0200719A3 (en) 2004-11-29
ATE316153T1 (de) 2006-02-15
NO20014969D0 (no) 2001-10-12
AU3563200A (en) 2000-11-02

Similar Documents

Publication Publication Date Title
Brogden et al. Device for the motor conditioning of small animals
Westman et al. Noise and stress: a comprehensive approach.
Pober et al. Williams syndrome: An overview of medical, cognitive, and behavioral features
NO20014969L (no) Diagnose av en persons risiko for utvikling av aterosklerose eller diabetisk retinopati
DE60314236D1 (de) Verfahren zur diagnose und therapie von schizophrenie
Call et al. Combined antecedent variables as motivating operations within functional analyses
HK1056574A1 (en) Materials and methods relating to protein aggregation in neurodegenerative disease
Millward A disability act? The vaccine damage payments act 1979 and the British Government’s response to the pertussis vaccine scare
DE60122673D1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
FI933291A0 (fi) Foerfarande foer paovisning av anti-rna-antikroppar
DE69728044D1 (de) Diagnostisches verfahren und gerät
GB2431348A (en) Agents and methods for early diagnosis and monitoring of alzheimer's disease and other neurological disorders
ATE163050T1 (de) Nucleotidsequenzen
Wagner et al. The treatment of nocturnal enuresis: A controlled comparison of two models of urine alarm
Coleman et al. Proposed standards of care for the treatment of adult sex offenders
Cook et al. Consent for aversive treatment: A model form
BG106583A (en) Diagnosis of a person's risk of developing alcoholism
Damy et al. Fundamental aspects on animal research as applied to experimental surgery
Newcombe et al. Rehabilitation after brain damage: an overview
Hunt Effects of Drugs on Emotional Responses and Abnormal Behavior in Animals.
O'Reilly et al. A preliminary investigation of the assessment and treatment of tantrums with two post-institutionalized Romanian adoptees
DE69013139D1 (de) Mittel zur Vorbeugung, Diagnose und Therapie von rheumatischen, autoimmunen, Haut- und Bindegewebekrankheiten von unbekannter Aetiologie und Verfahren zu seiner Herstellung und Verwendung.
ATE397090T1 (de) Verfahren und verbindungen zur diagnose von entzündlichen erkrankungen und identifizierung von pharmakologischen mitteln zur behandlung von entzündlichen erkrankungen
Surarith Women's Struggle for Housing Rights in Thailand
Yoder et al. Influences of disabling conditions on the nature and frequency of farm/ranch-related injuries

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application